- Home
- BDTX vs PIM Comparison
BDTX vs PIM Comparison
Compare BDTX & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- PIM
- Stock Information
- Founded
- BDTX 2014
- PIM 1988
- Country
- BDTX United States
- PIM United States
- Employees
- BDTX N/A
- PIM N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- PIM Finance Companies
- Sector
- BDTX Health Care
- PIM Finance
- Exchange
- BDTX Nasdaq
- PIM Nasdaq
- Market Cap
- BDTX 181.4M
- PIM 168.6M
- IPO Year
- BDTX 2020
- PIM N/A
- Fundamental
- Price
- BDTX $3.99
- PIM $3.42
- Analyst Decision
- BDTX Strong Buy
- PIM
- Analyst Count
- BDTX 5
- PIM 0
- Target Price
- BDTX $12.00
- PIM N/A
- AVG Volume (30 Days)
- BDTX 1.0M
- PIM 57.5K
- Earning Date
- BDTX 11-04-2025
- PIM 01-01-0001
- Dividend Yield
- BDTX N/A
- PIM 8.28%
- EPS Growth
- BDTX N/A
- PIM N/A
- EPS
- BDTX 0.25
- PIM 0.05
- Revenue
- BDTX $70,000,000.00
- PIM N/A
- Revenue This Year
- BDTX N/A
- PIM N/A
- Revenue Next Year
- BDTX N/A
- PIM N/A
- P/E Ratio
- BDTX $15.96
- PIM $63.80
- Revenue Growth
- BDTX N/A
- PIM N/A
- 52 Week Low
- BDTX $1.20
- PIM $2.90
- 52 Week High
- BDTX $4.10
- PIM $3.28
- Technical
- Relative Strength Index (RSI)
- BDTX 69.63
- PIM N/A
- Support Level
- BDTX $3.81
- PIM N/A
- Resistance Level
- BDTX $4.03
- PIM N/A
- Average True Range (ATR)
- BDTX 0.20
- PIM 0.00
- MACD
- BDTX 0.04
- PIM 0.00
- Stochastic Oscillator
- BDTX 91.58
- PIM 0.00
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.